Editorial: Time to move ahead with Calif. stem cell program

05/22/2007 | San Francisco Chronicle

With a three-year legal fight over, California's Institute for Regenerative Medicine needs to get on with the task of funding stem cell research, the San Francisco Chronicle said in an editorial. The institute faces limitations, the newspaper noted, but has the benefit of oversight by a group of universities and a research institute.

View Full Article in:

San Francisco Chronicle

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations